Jenburkt [JENBURPH] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Jenburkt

BSE
Loading...

Sun Pharmaceutical

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Jenburkt wins in 14 metrics, Sun Pharmaceutical wins in 6 metrics, with 0 ties. Jenburkt appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricJenburktSun PharmaceuticalBetter
P/E Ratio (TTM)14.8936.74Jenburkt
Price-to-Book Ratio2.815.30Jenburkt
Debt-to-Equity Ratio2.273.26Jenburkt
PEG Ratio2.91-1.89Sun Pharmaceutical
EV/EBITDA11.8823.33Jenburkt
Profit Margin (TTM)20.97%19.29%Jenburkt
Operating Margin (TTM)23.18%24.34%Sun Pharmaceutical
EBITDA Margin (TTM)23.18%24.34%Sun Pharmaceutical
Return on Equity18.66%15.08%Jenburkt
Return on Assets (TTM)16.34%11.87%Jenburkt
Free Cash Flow (TTM)$81.92M$119.44BSun Pharmaceutical
Dividend Yield2.48%1.26%Jenburkt
1-Year Return8.77%-14.34%Jenburkt
Price-to-Sales Ratio (TTM)3.127.11Jenburkt
Enterprise Value$4.67B$3,578.34BSun Pharmaceutical
EV/Revenue Ratio3.026.65Jenburkt
Gross Profit Margin (TTM)81.65%79.58%Jenburkt
Revenue per Share (TTM)$351$224Jenburkt
Earnings per Share (Diluted)$73.46$43.39Jenburkt
Beta (Stock Volatility)0.380.31Sun Pharmaceutical
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Jenburkt vs Sun Pharmaceutical Stock Performance Analysis

Loading Price Chart...

Jenburkt
Sun Pharmaceutical
Jenburkt Stock Overview | Sun Pharmaceutical Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Jenburkt-0.42%-1.85%-5.15%-20.20%5.78%-11.50%
Sun Pharmaceutical-0.31%0.56%4.66%-1.86%-3.66%-13.43%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Jenburkt8.77%96.74%188.92%120.06%1,195.02%2,298.67%
Sun Pharmaceutical-14.34%71.30%219.01%80.56%692.58%2,617.04%

News Based Sentiment: Jenburkt vs Sun Pharmaceutical

Jenburkt

News based Sentiment: MIXED

September presented a mixed bag for Jenburkt Pharmaceuticals, with positive year-over-year growth in revenue and profit countered by short-term declines and a negative market sentiment. The closure of the trading window signals an upcoming earnings release that will be pivotal in shaping the company's investment narrative.

View Jenburkt News Sentiment Analysis

Sun Pharmaceutical

News based Sentiment: MIXED

October was a mixed month for Sun Pharma, with a significant acquisition balanced against a decline in net profit. Positive analyst ratings and tariff news provide offsetting positive signals, making it a month of notable, but not overwhelmingly positive, developments for investors.

View Sun Pharmaceutical News Sentiment Analysis

Performance & Financial Health Analysis: Jenburkt vs Sun Pharmaceutical

MetricJENBURPHSUNPHARMA
Market Information
Market Cap i₹4.87B₹3.92T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,9452,839,112
90 Day Avg. Volume i1,2782,655,594
Last Close₹1,074.90₹1,631.20
52 Week Range₹936.70 - ₹1,410.00₹1,548.00 - ₹1,952.25
% from 52W High-23.77%-16.45%
All-Time High₹1,410.00 (Jul 08, 2025)₹1,960.35 (Sep 30, 2024)
% from All-Time High-23.77%-16.79%
Growth Metrics
Quarterly Revenue Growth0.09%0.10%
Quarterly Earnings Growth0.05%-0.20%
Financial Health
Profit Margin (TTM) i0.21%0.19%
Operating Margin (TTM) i0.23%0.24%
Return on Equity (TTM) i0.19%0.15%
Debt to Equity (MRQ) i2.273.26
Cash & Liquidity
Book Value per Share (MRQ)₹389.23₹300.99
Cash per Share (MRQ)₹52.44₹108.88
Operating Cash Flow (TTM) i₹252.79M₹110.84B
Levered Free Cash Flow (TTM) i₹320.61M₹109.29B
Dividends
Last 12-Month Dividend Yield i2.48%1.26%
Last 12-Month Dividend i₹33.30₹21.00

Valuation & Enterprise Metrics Analysis: Jenburkt vs Sun Pharmaceutical

MetricJENBURPHSUNPHARMA
Price Ratios
P/E Ratio (TTM) i14.8936.74
Forward P/E i31.3848.79
PEG Ratio i2.91-1.89
Price to Sales (TTM) i3.127.11
Price to Book (MRQ) i2.815.30
Market Capitalization
Market Capitalization i₹4.87B₹3.92T
Enterprise Value i₹4.67B₹3.58T
Enterprise Value Metrics
Enterprise to Revenue i3.026.65
Enterprise to EBITDA i11.8823.33
Risk & Other Metrics
Beta i0.380.31
Book Value per Share (MRQ) i₹389.23₹300.99

Financial Statements Comparison: Jenburkt vs Sun Pharmaceutical

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)JENBURPHSUNPHARMA
Revenue/Sales i₹355.27M₹137.86B
Cost of Goods Sold i₹65.18M₹28.15B
Gross Profit i₹290.09M₹109.71B
Research & Development iN/AN/A
Operating Income (EBIT) i₹82.35M₹33.72B
EBITDA i₹110.14M₹47.66B
Pre-Tax Income i₹101.82M₹31.73B
Income Tax i₹23.90M₹8.70B
Net Income (Profit) i₹77.92M₹22.93B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)JENBURPHSUNPHARMA
Cash & Equivalents i₹73.65M₹102.69B
Total Current Assets i₹565.32M₹526.24B
Total Current Liabilities i₹188.19M₹181.94B
Long-Term Debt i₹14.92M₹3.58B
Total Shareholders Equity i₹1.72B₹724.86B
Retained Earnings i₹1.62B₹578.62B
Property, Plant & Equipment i₹144.29M₹100.36B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)JENBURPHSUNPHARMA
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricJENBURPHSUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i1,9452,839,112
Average Daily Volume (90 Day) i1,2782,655,594
Shares Outstanding i4.41M2.40B
Float Shares i1.77M1.04B
% Held by Insiders i0.73%0.56%
% Held by Institutions i0.00%0.25%

Dividend Analysis & Yield Comparison: Jenburkt vs Sun Pharmaceutical

MetricJENBURPHSUNPHARMA
Last 12-Month Dividend i₹33.30₹21.00
Last 12-Month Dividend Yield i2.48%1.26%
3-Year Avg Annual Dividend i₹19.90₹14.67
3-Year Avg Dividend Yield i1.83%0.46%
3-Year Total Dividends i₹59.70₹44.00
Ex-Dividend DateJul 11, 2025Jul 07, 2025